Aster Dm Healthcare Ltd. · NSE:ASTERDM
Aster Dm Healthcare — Q2 FY2025 Earnings Presentation
38 slides from Aster Dm Healthcare's earnings presentation, Oct 23, 2024
Slide 1: Exchange filing cover letter for investor presentation
October 23, 2024 The Secretary The Manager, Listing Department, Listing Department, BSE Limited, The National Stock Exchange of India Ltd 1st Floor, Phiroze Jeejeebhoy Towers Exchange Plaza, C-1, Block G Dalal Street, Mumbai 400001 Bandra Kurla Complex Scrip Code: 540975 Bandra (East), Mumbai 400051
Slide 2: Earnings Presentation for the quarter ending September 30, 2024
Earnings Presentation For the quarter ending September 30, 2024
Slide 3: Disclaimer
Disclaimer • This presentation has been prepared by Aster DM Healthcare Limited (the "Company"), content of which was compiled from sources believed to be reliable for informational purposes only and are based on information regarding the Company and the economic, regulatory, market and other condit
Slide 4: H1 FY 2025 Performance Summary - Aster India
H1 FY 2025 Performance Summary- Aster India 3 Revenue Operating EBITDA1 PBT PAT2 RoCE (Pre-Tax) Financial (Post-NCI) H1FY25 : INR 2,088 cr H1FY25 : INR 410 cr H1FY25 : INR 284 cr H1FY25 : INR 171 cr H1FY25 : 18.0% 18% 44% 134% 88% 390 bps H1FY24 : INR 1,772 cr H1FY24 : INR 285 cr H1FY24 : INR 121 cr
Slide 5: Aster India Performance Summary – Q2 and H1 FY 2025
Aster India Performance Summary – Q2 and H1 FY 2025 ▪ Overall Operating EBITDA margin of 19.6% in H1 FY25 (16.1% in H1 FY24) ▪ Core hospital business delivered Operating EBITDA margin of 22.4% in H1 FY25 (19.1% in H1 FY24) ▪ Matured hospital Op. EBITDA margins at 25% in H1 FY25 (22% in H1 FY24) and
Slide 6: Company Overview
Company Overview
Slide 7: Aster India at a Glance
Aster India at a Glance Our Presence/Strength1 15 cities and 192 4,994 5 states Hospitals capacity beds 13 232 212 Clinics Labs and PECs Pharmacies3 Operational metrics (H1 FY25) Karnataka & Maharashtra 69% 3.2 days INR 43,600+ Karnataka Hospital: 4, Beds: 1192 Occupancy ALOS ARPOB Maharashtra Andhr
Slide 8: Our Vision and Core Values
Our Vision and Core Values Excellence Respect “Surpassing current benchmarks constantly by continually “Treating people with utmost dignity, valuing challenging its ability and skills their culture contributions and fostering a Our Promise to take the organisation to culture that allows each individ
Slide 9: Aster India Revenue and Profitability Snapshot – H1 FY25
Aster India Revenue and Profitability Snapshot – H1 FY25 8 Revenue from Operations 1 Operating EBITDA and Margin1,2 EBITDA and Margin 1 PAT and Margin 3 (Post Ind As) (Post NCI) 16.1% 19.6% 15.3% 18.4% 5.1% 8.2% 2,088 410 383 171 1,772 271 285 91 H1FY24 H1FY25 H1FY24 H1FY25 H1FY24 H1FY25 H1FY24 H1FY
Slide 10: Aster India Revenue and Profitability Snapshot – Q2 FY25
Aster India Revenue and Profitability Snapshot – Q2 FY25 9 Revenue from Operations 1 Operating EBITDA and Margin1,2 EBITDA and Margin 1 PAT and Margin 3 (Post Ind As) (Post NCI) 16.8% 21.4% 410 15.9% 20.2% 5.4% 8.9% 1,086 233 97 220 934 285 157 148 50 15.3% 17.7% Q2FY24 Q2FY25 Q2FY24 Q2FY25 Q2FY24 Q
Slide 11: Aster India Hospital and other New Business Performance – H1 FY25
Aster India Hospital and other New Business Performance – H1 FY25 % of Revenue Revenue Operating EBITDA(5) Hospitals and Clinics INR 2,019 Cr INR 453 Cr 20% 22.4% 94% Core established business YoY Revenue Growth Margins 19 hospitals(1) 13 clinics 4,994 capacity beds Labs and Pharmacies INR 130 Cr IN
Slide 12: Core Business Performance- Hospitals and Clinics
Core Business Performance- Hospitals and Clinics
Slide 13: Aster India - Hospital Financial Trends
Aster India - Hospital Financial Trends Hospital Operating EBITDA 1 Hospital Revenue Hospital EBITDA and Margin and Margin (In INR Cr) (In INR Cr) 19% 22% 11% 13% 12% 17% 19% 20% Margin 3,519 2,019 688 2,851 453 1,682 538 2,343 322 407 1,631 1,647 1,307 212 201 143 H1FY24 H1FY25 FY19 FY20 FY21 FY22
Slide 14: Aster India – Hospital Operational Trends
Aster India – Hospital Operational Trends No. of Hospitals No. of capacity beds Total patient volumes (In Mn) 4,994 4,867 3.3 4,855 19 19 19 1.8 4,317 2.9 17 3,905 1.6 3,693 3,757 3,460 14 14 2.2 2.2 13 12 1.8 1.5 H1FY24 H1FY25 FY19 FY20 FY21 FY22 FY23 FY24 H1FY24 H1FY25 FY19 FY20 FY21 FY22 FY23 FY2
Slide 15: Aster India - Hospitals & Clinics Revenue Mix
Aster India - Hospitals & Clinics Revenue Mix Geographical Revenue Mix1 (H1 FY25) Specialty-wise Revenue Mix (H1 FY25) Andhra & Telangana 12% Multi Speciality, 18% Cardiac Sciences , 14% Kerala 54% OP Pharmacy, Neuro Sciences, 11% Karnataka & Anaestheolgy, 13% Maharashtra 34% Child and Adolscent Hea
Slide 16: Aster India - Maturity Wise Hospital Performance – H1 FY25
15 Aster India - Maturity Wise Hospital Performance – H1 FY25 Key Performance indicators Operational Revenue3,5 Operating Maturity Hospitals Beds Operating (INR in Crs.) ARPOBD Occupancy EBITDA3,5,7 ROCE8 (Census)6 EBITDA % (INR Crs.) Over 6 73% 70% 10 ₹1,447 ₹ 45,100 69% ₹356 24.6% 32% Years 2,568
Slide 17: Aster India Hospitals: Pipeline Projects
16 Aster India Hospitals: Pipeline Projects Further addition of ~1800 beds, bringing the total bed capacity to ~6,800 by FY27 454 6,796 35 1 3 4 5 159 5 FY27 : 904 beds 4,994 1 FY26 : 639 beds FY25 : 334 beds Aster H1 Aster Aster Ramesh Aster MIMS Aster MIMS Aster W&C Aster Aster Aster Capital White
Slide 18: Growth Strategy
Our strategic priorities towards driving future growth and improvement in profitability Focus Areas Capital ✓ Investing prudently in both brownfield (expanding existing units) and greenfield Investment A projects across clusters and opportunistically exploring inorganic opportunities Operational ✓ F
Slide 19: Aster India Financial Summary- Profitability Statement
Aster India Financial Summary- Profitability Statement Particulars Q2 FY25 Q2 FY24 YoY % H1 FY25 H1 FY24 YoY % Revenue from Operations 1,086 934 16% 2,088 1,772 18% Material Cost2 237 236 466 455 Doctors Cost 236 199 462 383 Employee Cost 193 172 384 328 Other Cost 187 170 366 322 Operating EBITDA 2
Slide 20: Financial Summary – Balance Sheet and Ratios
Financial Summary – Balance Sheet and Ratios 19 Particulars (INR Cr) As at Sep 30, 2024 As at Mar 31, 2024 As at Mar 31, 2023 LIABILITIES Shareholder’s Equity 500 500 500 Minority Interest 166 158 157 Other Reserves 2,476 897 719 Revalution Reserve 460 460 460 Gross Debt 591 669 597 Lease Liabilitie
Slide 21: Cluster Performance
Cluster Performance
Slide 22: Kerala Cluster: Hospitals and Bed Capacity
Kerala Cluster: Hospitals and Bed Capacity Revenue Contribution1 54% Aster Medcity MIMS Calicut MIMS Kottakkal Kochi, Kerala Kozhikode, Kerala Kottakkal, Kerala 2014, Owned 2013, Owned 2013, Owned CB: 762 OB: 625 CB: 698 OB: 476 CB:340 OB:263 MIMS Kannur Aster PMF Aster Mother Hospital Kannur, Keral
Slide 23: Kerala Cluster - Performance
Kerala Cluster - Performance Revenue (In INR Crs) 1,087 2,007 965 1,691 1,318 Operational Metrics H1 FY25 H1 FY24 YoY Growth 875 935 701 ARPOBD (INR) 41,200+ 37,100+ 11% H1FY24 H1FY25 FY19 FY20 FY21 FY22 FY23 FY24 Operating EBITDA1 (In INR Crs) Occupancy 77% 80% -300 bps 259 430 199 H1 FY25 356 255
Slide 24: Karnataka & Maharashtra Cluster : Hospitals and Bed Capacity
Karnataka & Maharashtra Cluster : Hospitals and Bed Capacity Revenue Contribution1 34% Aster CMI Aster Whitefield Aster RV Bengaluru, Karnataka Bengaluru, Karnataka Bengaluru, Karnataka 2014, O&M 2021, Leased 2019, O&M CB: 509 OB:368 CB: 347 OB:223 CB: 236 OB:168 Aster Aadhar Aster G Madegowda Kolha
Slide 25: Karnataka & Maharashtra Cluster - Performance
Karnataka & Maharashtra Cluster - Performance Revenue (In INR Crs) 696 1100 516 817 Operational Metrics H1 FY25 H1 FY24 YoY Growth 655 442 433 310 ARPOBD (INR) 58,600+ 52,300+ 12% H1FY24 H1FY25 FY19 FY20 FY21 FY22 FY23 FY24 Operating EBITDA1 Occupancy 65% 59% 600 bps H1 FY25 (In INR Crs) 164 217 150
Slide 26: Andhra & Telangana Cluster : Hospitals and Bed Capacity
Andhra & Telangana Cluster : Hospitals and Bed Capacity Revenue Contribution1 12% Ramesh Guntur Prime Hospitals – Ameerpet Ramesh Sanghamitra Guntur, AP Hyderabad, Telangana Ongole, AP 2016, Leased 2014, Leased 2018, Owned CB:350 OB:225 CB:158 OB:98 CB:150 OB:130 Aster Narayanadri Ramesh Main Centre
Slide 27: Andhra & Telangana - Performance
Andhra & Telangana - Performance Revenue (In INR Crs) 236 202 412 370 344 Operational Metrics H1 FY25 H1 FY24 YoY Growth 303 314 279 ARPOBD (INR) 29,100+ 27,800+ 5% H1FY24 H1FY25 FY19 FY20 FY21 FY22 FY23 FY24 Operating EBITDA1 Occupancy 56% 49% 700 bps (In INR Crs) H1 FY25 30 69 21 Average Occupied
Slide 28: Awards, Excellence & Leadership
Awards, Excellence & Leadership
Slide 29: Awards
Awards Outlook 2024 Best Hospital Ranking Best Multispecialty Hospital Emerging Times All India Multispecialty Hospital Ranking 2024 Aster Medcity : All India Best Multispeciality 2 Aster Medcity: All India 1 Aster CMI Hospital: All India 4 Aster Medcity: India Best Multispecialty 3 Hospital Aster C
Slide 30: Clinical Highlights
29 Clinical Highlights TTM basis 11 500+ 1600+ 2400+ 3300+ 5600+ 6600+ Total number of research Total number of Total number of Robotic Total Number of Total number of Total number of Total number of paper published in indexed Transplants Surgeries Cardiovascular Surgeries Joint Replacements Neurosu
Slide 31: ESG Milestones
ESG Milestones 30 93% 85% 13 2,300,000 KWh 3,675,000 KWh 4300 E Energy Consumption sourced from renewable Energy Consumption sourced from renewable Sewage treatment plants installed across India Worth wind energy sourced Worth solar energy sourced Trees Planted energy at Aster CMI, energy at Aster R
Slide 32: Board of Directors
Board of Directors 31 Shamsudheen Bin Dr. Azad Moopen Alisha Moopen T. J. Wilson Mohideen Mammu Haji Founder Chairman and Managing Deputy Managing Director Non-Executive Director Non-Executive Director Director Purana Housdurgamvijaya Chenayappillil John James Mathew Emmanuel David Gootam Deepti Geo
Slide 33: Leadership Team
32 Leadership Team Dr. Azad Moopen Founder Chairman and Managing Director T. J. Wilson Ramesh Kumar S Dr.Somashekhar S P Sunil Kumar M R Group Head - Governance & Chief Operating Officer Chairman of Medical Advisory Council and Global Director Chief Financial Officer Corporate Affairs Hitesh Dhaddha
Slide 34: Appendix
Appendix
Slide 35: Aster India Hospital and other New Business Performance – Q2 FY25
Aster India Hospital and other New Business Performance – Q2 FY25 % of Revenue Revenue Operating EBITDA(5) Hospitals and Clinics INR 1,051 Cr INR 252 Cr 19% 24% 94% Core established business YoY Revenue Growth Margins 19 hospitals(1) 13 clinics 4,994 capacity beds Labs and Pharmacies INR 68 Cr INR 4
Slide 36: Geography – wise Business – Snapshot – H1 FY25
Geography – wise Business – Snapshot – H1 FY25 35 KARNATAKA & ANDHRA & KERALA TOTAL MAHARASHTRA TELANGANA H1 FY25 H1 FY24 H1 FY25 H1 FY24 H1 FY25 H1 FY24 H1 FY25 H1 FY24 Total Capacity Beds 2,501 2,385 1,446 1,423 1,047 1,047 4,994 4,855 Operational Beds (Census) 1,898 1,833 1,010 918 781 790 3,689
Slide 37: Geography – wise Business – Snapshot – Q2 FY25
Geography – wise Business – Snapshot – Q2 FY25 36 KARNATAKA & ANDHRA & KERALA TOTAL MAHARASHTRA TELANGANA Q2 FY25 Q2 FY24 Q2 FY25 Q2 FY24 Q2 FY25 Q2 FY24 Q2 FY25 Q2 FY24 Total Capacity Beds 2,501 2,385 1,446 1,423 1,047 1,047 4,994 4,855 Operational Beds (Census) 1,898 1,833 1,010 918 781 790 3,689
Slide 38: Thank You
Thank You Investor Relations: investors@asterdmhealthcare.com
Aster DM Healthcare — Q2 FY2025 Earnings Presentation on 6ix